biochemical markers

Related by string. * Biochemical . biochemicals . Biochemicals : activate biochemical pathways . biochemical recurrence . biochemical relapse . biochemical pathways . biochemical processes . Biochemical Zoology . Krebs Biochemicals / Markers . MARKERS . markered : BETWEEN MILE MARKERS . surrogate markers . grave markers . paintball markers . crayons markers . serum markers . markers crayons * *

Related by context. All words. (Click for frequent words.) 67 metabolic parameters 65 biochemical abnormalities 65 biochemical marker 65 serum markers 64 scintigraphic 64 intact parathyroid hormone 64 serum biomarkers 64 molecular biomarkers 63 B7 H3 63 metabolite concentrations 63 DNA methylation patterns 63 inflammatory biomarkers 63 troponins 63 APOE genotype 62 lactate dehydrogenase 62 radiographic findings 62 metabolomic profiles 62 TNFalpha 62 biomarkers 62 serum lipid 62 miRNA expression 62 genetic polymorphisms 62 FDG uptake 62 myocyte 62 telomere lengths 61 Leydig cell 61 p# activation 61 serum concentrations 61 macrophage infiltration 61 TPMT 61 subclinical disease 61 histone modifications 61 ovarian hormones 61 thyroid stimulating hormone 61 pharmacokinetic parameters 61 tumor histology 61 methylation patterns 61 prostate cancer CaP 61 N telopeptide 61 K ras mutations 61 thyrotropin 61 plasma lipids 61 hamartomas 61 urinary albumin 61 pressor response 61 MR spectroscopy 61 monoclonal gammopathy 61 adrenal function 61 eosinophil count 61 GAGs 60 macroalbuminuria 60 serum lipid levels 60 pulmonary toxicity 60 pathologic fractures 60 serum PSA 60 bronchoalveolar lavage 60 microsatellite instability 60 histopathological 60 epigenetic markers 60 serum cortisol 60 acetabular dysplasia 60 myeloperoxidase 60 metabolic abnormality 60 metabolic dysfunction 60 thyroid carcinoma 60 serum PTH 60 incidentalomas 60 bone scintigraphy 60 osteocalcin 60 thyroid dysfunction 60 murine model 60 microRNA expression 60 oxysterols 60 cerebrospinal fluid CSF 60 gene expression patterns 60 mRNA expression 60 isoprostanes 60 leukocyte counts 60 diagnostic biomarker 60 urolithiasis 60 alanine aminotransferase ALT 60 cTnT 60 micronuclei 60 mitochondrial proteins 60 histone acetylation 60 F FDG PET 60 gadolinium enhanced 60 liver histology 59 overt hypothyroidism 59 autonomic dysfunction 59 MSMB 59 brain lesions 59 albumin excretion 59 biomarker 59 Subgroup analyzes 59 lipid parameters 59 nAChR 59 subclinical atherosclerosis 59 prognostic markers 59 subclinical 59 chromosome aberrations 59 gene polymorphisms 59 C1q 59 aminotransferases 59 pulmonary metastases 59 C telopeptide 59 timepoint 59 protein excretion 59 pre malignant lesions 59 sonographic findings 59 spirometric 59 carcinoembryonic antigen 59 hemodilution 59 specific antigen PSA 59 Logistic regression 59 cystatin C 59 glycosylated hemoglobin HbA1c 59 motor neuron degeneration 59 thyrotropin levels 59 antigen PSA levels 59 genetic determinants 59 hypericin 59 serum TSH 59 ERalpha 59 artery stenosis 59 Lp PLA 2 59 prostate cancer PCa 59 nanomolar 59 surrogate markers 59 plasma lipid 59 stratifying patients 59 epithelial tumors 59 cardiac troponin 59 HER2 expression 59 lactate dehydrogenase LDH 59 mineral density 59 fFN 59 systemic inflammation 59 missense mutations 59 prostatic fluid 59 bone metabolism 59 troponin T 59 proteoglycan 59 cortisol concentrations 59 breast cancer subtypes 59 serum calcium 59 immunoreactivity 59 cardiac biomarkers 59 breast carcinoma 59 follicle stimulating hormone FSH 59 microalbuminuria 59 intima media thickness 59 prognostic significance 59 thyroid hormone levels 59 bone resorption 59 CSF biomarkers 59 neuropathologic 59 IL 1ß 59 immunostaining 59 lipid levels 59 intravenous bisphosphonates 59 CTEPH 59 prognostic indicator 59 lipid profiles 59 prognostic indicators 59 prognostic marker 59 atherogenic dyslipidemia 59 colorectal adenoma 59 VA# [002] 59 hematological parameters 59 urinary excretion 58 pharmacodynamic markers 58 mtDNA mutations 58 nodal metastasis 58 urine cytology 58 carotid IMT 58 creatinine levels 58 alanine aminotransferase 58 gene expression profiles 58 radiotracers 58 MGUS 58 aspartate aminotransferase 58 #F FDG PET 58 immunohistochemical staining 58 RRM1 58 spermidine 58 immunohistochemical 58 adipokines 58 MTHFD1L gene 58 natriuretic peptides 58 atypical hyperplasia 58 Prostatitis 58 eosinophilia 58 biochemical recurrence 58 Cotinine 58 EGFR expression 58 vimentin 58 chorioamnionitis 58 Clusterin 58 pathophysiological mechanisms 58 circadian genes 58 parathyroid hormone PTH 58 interleukin IL -6 58 genetic loci 58 morphologic 58 urate levels 58 endometrial hyperplasia 58 plasma pharmacokinetics 58 hepatic fibrosis 58 endothelial activation 58 perfusion defects 58 reticulocytes 58 β blockers 58 arterial calcification 58 pathophysiological 58 postoperative mortality 58 pCR 58 mucosal lesions 58 anti JCV antibodies 58 urinary calcium 58 ABCB1 58 TGF ß1 58 proto oncogene 58 pharmacodynamic biomarkers 58 underlying pathophysiology 58 serum phosphate 58 metabolic disturbances 58 differentially expressed genes 58 pituitary hormone 58 Inhibin B 58 carbohydrate metabolism 58 PON1 58 AST ALT 58 prognostic factor 58 leiomyomas 58 sonographic appearance 58 aromatase inhibitor therapy 58 clinicopathological 58 angiographically 58 telomerase activity 58 fasting insulin 58 SGPT 58 CLA supplementation 58 prognostic biomarker 58 estrone 58 prognostic factors 58 GSTP1 58 hematological relapse 58 sonographic diagnosis 58 GBA mutations 58 serum lipids 58 chromosomal aberrations 58 DHEA supplementation 58 serum antibodies 58 rs# [004] 58 pharmacodynamic parameters 58 hypothalamic pituitary 58 splice variants 58 soluble CD# ligand 58 urothelial cancer 58 isotypes 58 GSTT1 58 CD# expression [001] 58 inflammatory markers 58 androgen deficiency 58 epithelial barrier 58 clefting 58 urine NGAL 58 colorectal carcinoma 58 gastric carcinoma 58 hypercalciuria 58 genes differentially expressed 58 somatic mutations 58 neurocognitive function 58 amyloid deposition 58 thyroglobulin 58 liver fibrosis 58 pleural fluid 58 Heavy menstrual bleeding 58 familial clustering 58 antitumor efficacy 58 overt nephropathy 58 myocardial ischemia 58 histologic examination 58 Microalbuminuria 58 immune modulating 58 prostate carcinoma 58 microdeletion 58 genetic variants associated 58 human chorionic gonadotrophin 57 myometrium 57 ACh 57 postoperative radiotherapy 57 apo B 57 endometrial carcinoma 57 PTPN# 57 serum calcium levels 57 FDG PET scans 57 virulence genes 57 lipid metabolism 57 liver biopsies 57 isoprostane 57 elevated CRP 57 cervical secretions 57 bronchoalveolar 57 aminotransferase 57 HbF 57 rs# [001] 57 metabolic abnormalities 57 caspofungin 57 cTnI 57 retinal nerve 57 transcranial Doppler 57 mTOR inhibitors 57 GFT# 57 preclinically 57 parasitemia 57 hip BMD 57 proton MR spectroscopy 57 calcitonin 57 S nitrosylation 57 elevated triglyceride levels 57 albuminuria 57 antiphospholipid antibodies 57 aortic stiffness 57 flavopiridol 57 extrapyramidal symptoms 57 Wnts 57 skin sterol 57 transient elastography 57 serum estradiol 57 Endothelial dysfunction 57 OGG1 57 QTc prolongation 57 fibrin deposition 57 alkaline phosphatase ALP 57 melanocyte stimulating hormone 57 tissue biopsies 57 posttransplant 57 hamartoma 57 malignant transformation 57 abnormal glucose metabolism 57 Chronic pancreatitis 57 mammographically 57 EBUS FNA 57 aetiology 57 potent inhibitors 57 microglial 57 ultrastructure 57 serum testosterone 57 Cystatin C 57 denervation 57 paricalcitol 57 induced sputum 57 immunohistochemical analysis 57 metabolizing enzyme 57 etiologic 57 genotypic resistance 57 biomarker assay 57 telomere shortening 57 glycated hemoglobin levels 57 gonadotropins 57 vascular dysfunction 57 osteosarcomas 57 pathophysiologic 57 SNP rs# [001] 57 antioxidant supplementation 57 serum testosterone levels 57 adipogenic 57 LVNC 57 tryptase 57 neurocognitive deficits 57 PEDF 57 biopsied tissue 57 posttranslational modifications 57 LHRH agonists 57 airway responsiveness 57 adiponectin levels 57 Cyclin E 57 Cathepsin B 57 lipid lowering agents 57 mineral density BMD 57 hemoglobin Hb 57 oxidized lipids 57 central corneal thickness 57 susceptibility loci 57 electron beam computed tomography 57 cAMP signaling 57 tumor necrosis 57 creatine kinase 57 tissue oxygenation 57 EGFR mutation status 57 glomerular filtration 57 amenorrhea 57 genomewide 57 BH4 57 SLC#A# [002] 57 cytokeratin 57 ischemic lesions 57 NNRTI resistance 57 thyroid nodules 57 haemolysis 57 IGF IR 57 radioiodine therapy 57 rs# [002] 57 glucocorticoid hormones 57 apelin 57 serum albumin 57 mammographic density 57 thyrotoxicosis 57 IgG4 57 endothelial dysfunction 57 histopathologic examination 57 FDG PET imaging 57 leiomyoma 57 estrogen metabolites 57 precursor lesions 57 phosphate S1P 57 intravesical therapy 57 hypermethylation 57 HER2 amplification 57 vascular reactivity 57 hyperinsulinemia 57 left ventricular diastolic 57 extramedullary 57 genetic polymorphism 57 hydroxyvitamin D levels 57 nitrotyrosine 57 prostate carcinogenesis 57 FGF2 57 hMG 57 triacylglycerol 57 vascular abnormalities 57 ADAMTS# 57 cardio respiratory fitness 57 nonalcoholic steatohepatitis NASH 57 cardioprotective effects 57 Logistic regression analysis 57 postoperative morbidity 57 p#INK#a 57 carotid artery thickness 57 chromosomal anomalies 57 methylation markers 57 #F FDG 57 epithelial tissues 57 tumor biopsies 57 phenotypic expression 57 microglial activation 57 Hashimoto thyroiditis 57 BRAF mutation 57 molecular abnormalities 57 echocardiographic parameters 57 neoplasm 57 axillary lymph nodes 57 mitochondrial metabolism 57 serum urate levels 57 primary aldosteronism 57 p# antigen 57 ischaemia 57 basal cell nevus syndrome 57 mitochondrial toxicity 57 beta1 integrin 57 activated microglia 57 Lipoic acid 57 neuropathological 57 arterial inflammation 57 transthyretin 57 sensitivity specificity 57 tumorigenicity 57 premalignant lesions 57 platelet reactivity 57 Tasigna prolongs 57 coronary stenosis 56 varicocele 56 FDG PET 56 carcinoid tumor 56 coagulation parameters 56 abdominal adiposity 56 lipoprotein levels 56 PlGF 56 karyotypes 56 KRAS status 56 genomic alterations 56 radiographic outcomes 56 chromosomal rearrangement 56 abnormal vaginal bleeding 56 rCBF 56 lipid abnormalities 56 Circulating tumor cells 56 arrhythmogenic 56 homodimers 56 intermittent hypoxia 56 erythrocyte sedimentation rate 56 pulmonary arterial 56 RQ PCR 56 serum lactate 56 LHRH agonist 56 BMD measurements 56 breast endometrial 56 osteoblastic 56 Sjögren syndrome 56 intestinal permeability 56 serum homocysteine 56 perfusion MRI 56 seminomas 56 bisphosphonate drugs 56 sarcosine 56 scintigraphy 56 hyperplastic 56 arthrography 56 pharmacodynamic effects 56 isoenzyme 56 obstructive CAD 56 clusterin 56 fluorodeoxyglucose 56 inhibin B 56 ultrastructural 56 hyperintense lesions 56 sitosterol 56 ADAM# 56 atherosclerosis regression 56 NMIBC 56 total cholesterol triglycerides 56 platelet activation 56 atherosclerotic vascular disease 56 biologic pathways 56 triiodothyronine 56 breast cancer metastasis 56 radiographically 56 ERK signaling 56 adenomatous 56 polycystic ovary syndrome PCOS 56 neuroregenerative 56 HAAH 56 PSA nadir 56 tissue fibrosis 56 physiologic parameters 56 MMP# 56 coronary calcification 56 tumor hypoxia 56 Leydig cells 56 systemic amyloidosis 56 hyperalgesia 56 Sarcopenia 56 cardiac troponin T 56 FGFR2 gene 56 thromboembolic disease 56 vaginal flora 56 palmitoleate 56 CYP#A# gene 56 hyperoxaluria 56 telomerase activation 56 malondialdehyde MDA 56 micrometastasis 56 elevated uric acid 56 SHBG levels 56 hsCRP levels 56 carcinoid 56 hemoglobins 56 radiotracer 56 erythropoiesis 56 atherogenic 56 neurological abnormalities 56 plasma triglycerides 56 fasting glucose levels 56 anabolism 56 inducible nitric oxide synthase 56 radioimmunoassay 56 dehydroepiandrosterone sulfate 56 impaired glucose metabolism 56 thyroxine T4 56 essential thrombocythemia 56 cardiac magnetic resonance 56 plain radiographs 56 lymph node metastasis 56 mesenchymal stromal cells 56 plasma kallikrein inhibitor 56 Akt activation 56 NGAL 56 genotoxicity 56 lipid concentrations 56 PSADT 56 paraneoplastic 56 Abeta# 56 chemosensitivity 56 serum cotinine levels 56 stent stenosis 56 neurosensory 56 Genetic variants 56 Parathyroid hormone 56 Haptoglobin 56 HepG2 cells 56 E selectin 56 TIMP 56 obstructive coronary artery 56 microdeletions 56 adrenocortical 56 Thyroid hormone 56 ptau 56 serous ovarian cancer 56 DNA methylation markers 56 FGFs 56 aminotransferase levels 56 Elevated serum 56 anticancer activity 56 glaucomatous 56 bezafibrate 56 metabolizer 56 subclinical hypothyroidism 56 gene expression 56 vascularity 56 CC genotype 56 riociguat 56 lichen planus 56 ibandronate 56 transferrin saturation 56 gastric adenocarcinoma 56 transaminase levels 56 ALB # 56 myo inositol 56 lipoprotein metabolism 56 signaling cascades 56 mechanistic studies 56 CEACAM1 56 KRAS oncogene 56 MetAP2 56 enzyme cofactor 56 dietary carbohydrate 56 myocardial perfusion 56 malondialdehyde 56 leucocyte 56 PITX2 56 chromosomal mutations 56 recurrent miscarriage 56 serine protease 56 constitutively expressed 56 CP CPPS 56 calcium phosphorus 56 amino acid metabolism 56 kallikrein 56 germline mutations 56 aneuploidies 56 growth hormone secretion 56 Genetic predisposition 56 cholestasis 56 Monocyte 56 cystic lesions 56 autoregulation 56 adipocyte differentiation 56 circulating endothelial cells 56 telomere length 56 airway hyperresponsiveness 56 myocardial necrosis 56 VE cadherin 56 locoregional recurrence 56 ADPKD 56 IgA deficiency 56 myocardial dysfunction 56 pleomorphic 56 multivariable analysis 56 cerebral microbleeds 56 explanatory variables 56 multivariate analyzes 56 histopathological examination 56 serum cholesterol 56 CYT# potent vascular disrupting 56 erythropoietic 56 Subgroup analysis 56 calculi 56 aberrant methylation 56 CYP#D# genotype 56 femoral neck fracture 56 cortical activation 56 synovial 56 serum prostate 56 transcranial Doppler ultrasound 56 TMEM#B 56 carotid atherosclerosis 56 promoter methylation 56 steroid hormones 56 aneuploidy 56 multiplex assay 56 node metastases 56 hematopoietic cancers 56 neutrophil gelatinase associated lipocalin 56 NRF2 gene 56 chest radiographs 56 hydroxyvitamin D concentrations 56 myeloproliferative diseases 56 cardiac fibrosis 56 eTag assays 56 intestinal microflora 56 Elocalcitol 56 Multivariate logistic regression 56 mitochondrial biogenesis 56 da mage 56 ELISpot 56 androgen deprivation 56 busulfan 56 idiopathic intracranial hypertension 56 plasma kallikrein 56 perilipin 56 estrogen receptor ER 56 immunofluorescence microscopy 56 2D 4D ratio 56 cathepsins 56 gene polymorphism 56 endothelial progenitor cells 56 hypothalamic pituitary adrenal axis 56 Endothelial 56 CD# expression [002] 56 Estradiol 56 metabolomic profiling 56 myocardial uptake 56 histopathologic diagnosis 56 lymphocytic 56 interferon beta therapy 56 transfusion syndrome 56 CIN3 56 TTR gene 56 morphometric vertebral fractures 56 mitochondrial mutations 56 estrogen deficiency 56 TNFa 56 nattokinase 56 neuroprotective effects 56 plasma adiponectin 56 hepatic enzymes 56 IL6 56 chromosomal instability 56 S#A# [002] 56 mesothelin 56 glomerular 56 gene loci 56 glucose homeostasis 56 florbetaben 56 genomic biomarker 56 rheumatoid factor 56 PIGF 56 mucinous 56 gamete formation 56 autophagic 56 myelofibrosis polycythemia vera 56 hs CRP 55 sporadic ALS 55 Insulin sensitivity 55 LRP5 55 lipoprotein 55 clevidipine 55 sweat chloride 55 receptor subtypes 55 haematopoietic 55 serum HBV DNA 55 DHEAS 55 transgenic rats 55 myeloproliferative neoplasms 55 CagA 55 PTHrP 55 genetic locus 55 anterior pituitary 55 urothelial carcinoma 55 Epidemiologic studies 55 vertebral fracture 55 C. pneumoniae 55 diagnostic biomarkers 55 PITX2 methylation 55 flow mediated dilation 55 soluble fms 55 potentiation 55 elastase 55 penetrance 55 LRRK2 mutations 55 epigenetic alterations 55 JAK mutations 55 Immunohistochemical staining 55 peptide BNP 55 hyperphenylalaninemia HPA due 55 elevated serum creatinine 55 microvascular disease 55 androgenic 55 prognostic biomarkers 55 pro angiogenic 55 LUTS 55 nephrolithiasis 55 transcriptomic 55 procalcitonin 55 secondary hyperparathyroidism 55 nucleotide substitutions 55 lumbar spine bone 55 endotoxemia 55 parathyroid 55 depressive symptomatology 55 handgrip strength 55 bioactivity 55 endophenotypes 55 Immunohistochemical analysis 55 Ki# 55 thymosin 55 transabdominal 55 aetiological 55 PPARγ 55 tibiofemoral 55 carcinomatosis 55 aortic insufficiency 55 serum BDNF 55 egg follicles 55 osteopenic 55 Legg Calvé Perthes disease 55 apolipoproteins 55 KRAS mutation 55 vasodilatation 55 endoglin 55 neoplasias 55 thickness CIMT 55 hepatic cirrhosis 55 KLF4 55 perfusion imaging 55 T2DM 55 acyl CoA 55 dysglycemia 55 HBeAg 55 causative mutation 55 HER2 overexpression 55 unresectable tumors 55 liver steatosis 55 SNP rs# [002] 55 Bisphosphonate 55 serum aminotransferase levels 55 osteoblast 55 protein tyrosine phosphatase 55 Skeletal muscle 55 CDK inhibitor 55 lung epithelium 55 univariate analyzes 55 tyrosine phosphorylation 55 sCJD 55 gastric mucosa 55 ^ sup #m 55 meta regression 55 impair fertility 55 histologically 55 PTEN gene 55 logistic regression analysis 55 substrate specificity 55 Subclinical 55 chromosomal alterations 55 transgene expression 55 adenomyosis 55 perfusion CT 55 colocalization 55 abnormal lipid 55 bile acid metabolism 55 APOE e4 55 histological subtype 55 monocyte chemoattractant protein 55 glycated hemoglobin HbA1c 55 trophoblasts 55 osteoarthritic 55 methylation 55 urinary N telopeptide 55 LHRH receptor positive 55 antitumor effect 55 Bone density 55 positron emission tomography PET 55 laterality 55 DaTscan 55 LRP6 55 adenoma recurrence 55 colorectal neoplasia 55 thyroid stimulating hormone TSH 55 noninvasive imaging 55 microalbumin 55 atypia 55 precancerous tumors 55 cerebral oxygenation 55 H#K#me# 55 imatinib therapy 55 miRNA genes 55 myocardial tissue 55 therapeutic regimens 55 tHcy 55 renal cell carcinomas 55 PKCi 55 albumin excretion rate 55 glycogen metabolism 55 synovial tissue 55 IDH1 mutation 55 bladder carcinoma 55 myocardial function 55 hematopoietic cells 55 chitinase 55 detrusor 55 osmolality 55 epididymal 55 vasomotor symptoms 55 cortisol secretion 55 chromosomal regions 55 treat benign prostatic 55 cell adhesion molecule 55 Previous epidemiological studies 55 VADT 55 Quantitation 55 heterozygotes 55 DGAT1 55 physiological abnormalities 55 Creatinine 55 tumor subtypes 55 alpha fetoprotein AFP 55 mGluR2 NAM 55 molecular determinants 55 chlamydial 55 interstitial fluid 55 symptomatic VTE 55 oxidases 55 antigen PSA 55 SCr 55 QT intervals 55 HNSCC 55 carotid bruit 55 postmenopausal hormones 55 cytopenias 55 specific alkaline phosphatase 55 inactivating mutations 55 endometrial 55 parkinsonism 55 plasma renin activity 55 lipoxygenase 55 normal karyotype 55 dopamine transporter 55 polycythemia vera PV 55 PrPSc 55 metabolic derangements 55 nonalcoholic steatohepatitis 55 ESBA# 55 PICALM 55 molecular mechanisms underlying 55 gliosis 55 decompensated cirrhosis 55 tumoral 55 coronary microvascular 55 ovulatory dysfunction 55 MLH1 55 pamidronate 55 osteochondroma 55 serum retinol 55 hypoxia inducible factor 55 vivo potency 55 idiopathic pulmonary 55 myopathies 55 colorectal adenomas 55 sentinel lymph nodes 55 PCa 55 alkalosis 55 eicosanoids 55 serum thyroglobulin 55 glucocorticoid receptors 55 cell adhesion molecules 55 cytoreductive surgery 55 Wnt proteins 55 testicular tumors 55 teratogens 55 oxidized cysteine 55 hypermethylated 55 anti Xa 55 pathological hallmark 55 Smurf1 55 metabolic acidosis 55 liver transplant recipients 55 A3 adenosine receptor 55 molecular markers 55 Mutational 55 nonfasting triglyceride levels 55 serum leptin 55 subclinical hyperthyroidism 55 HLA DRB1 * 55 p# MAPK 55 antidiabetic medications 55 transesophageal echocardiography 55 lateral radiograph 55 progranulin 55 EGFR inhibition 55 Cytogenetic 55 prefrontal cortical 55 Estrogen Receptor 55 Immunohistochemistry 55 preeclamptic 55 intravenous cyclophosphamide 55 neurodevelopmental outcomes 55 serum selenium 55 STRIDE PD 55 ductal carcinomas 55 Calcium intake 55 predisposing factor 55 glycolipids 55 cardiorespiratory fitness 55 Brugada syndrome 55 peritoneal fluid 55 familial ALS 55 cardioprotection

Back to home page